Tag: immunotherapy treatment
-
Immutep Ltd. Reports Strong Survival Data in Head and Neck Cancer Immunotherapy Trial
Immutep Ltd. made a significant announcement regarding the strong median overall survival of 17.6 months in cohort B of the TACTI-003 (Keynote-PNC-34) phase…